← back to search

Bryan M. Clary

University of San Diego · US
Area of research
Oncology · Hepatology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, and Colorectal Cancer Treatments and Studies.
h-index
65
citations
16,973
works
257
NIH funding
primary concept
email

Recent publications

Long-term Outcomes Associated With Open vs Endovascular Abdominal Aortic Aneurysm Repair in a Medicare-Matched Database
JAMA Network Open 2022cited by 95position: middledoi
Proposal of a New Comprehensive Notation for Hepatectomy
Annals of Surgery 2021cited by 187position: middledoi
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis
EClinicalMedicine 2020cited by 717position: lastdoi
Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers
International Journal of Cancer 2020cited by 74position: middledoi
Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons
Annals of Surgery 2020cited by 74position: middledoi
Positive Surgical Margins in the 10 Most Common Solid Cancers
Scientific Reports 2018cited by 277position: middledoi
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma
JAMA Surgery 2014cited by 361position: middledoi
Hepatobiliary Cancers, Version 2.2014
Journal of the National Comprehensive Cancer Network 2014cited by 129position: middledoi
Recurrence after operative management of intrahepatic cholangiocarcinoma
Surgery 2013cited by 289position: middledoi
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma
Cancer 2012cited by 212position: middledoi
Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis
Journal of the American College of Surgeons 2012cited by 139position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Timothy M. Pawlik · Columbus Oncology and Hematology Associates3 papers (2012–2014)Eduardo Barroso · Hospital Son Llatzer2 papers (2012–2014)Isaac Naazie · University at Buffalo, State University of New York2 papers (2020–2022)David A. Geller · Kumamoto University2 papers (2012–2012)Asma Mathlouthi · Oregon Health & Science University2 papers (2020–2022)Mechteld C. de Jong · Johns Hopkins Medicine2 papers (2012–2012)Todd W. Bauer · University of Virginia2 papers (2012–2014)Gilles Mentha · University Hospital of Geneva2 papers (2012–2014)Hugo P. Marques · Hospital da Luz2 papers (2012–2014)Nadin Elsayed · Southern Illinois University School of Medicine2 papers (2020–2022)Michael A. Choti · Banner - University Medical Center Phoenix1 papers (2012–2012)Mahmoud B. Malas · Janssen (United States)1 papers (2022–2022)Ezra E.W. Cohen · University of Michigan1 papers (2018–2018)J. Wallis Marsh · Max Planck Institute for Biology1 papers (2014–2014)Jason K. Sicklick · University of San Diego1 papers (2020–2020)Luca Aldrighetti · Erasmus MC Cancer Institute1 papers (2014–2014)T. Clark Gamblin · Medical College of Wisconsin1 papers (2014–2014)Christopher Kane · UC San Diego Health System1 papers (2018–2018)Ido Nachmany · Seattle University1 papers (2012–2012)Adam M. Burgoyne · Alder Hey Children's Hospital1 papers (2020–2020)